Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Targeted Oncology|January 5, 2021
Results and Clinical Utilization of Foundation Medicine Molecular Tumor Profiling in Uterine and Ovarian CancersCatherine H Watson, Gloria Broadwater, Janice Wong, et al.Cancer Discovery|December 3, 2017
Genomic Landscape of Cell-Free DNA in Patients with Colorectal CancerJohn H Strickler, Jonathan M Loree, Leanne G Ahronian, et al.Open Forum Infectious Diseases|July 16, 2026
Infectious Complications of CD19-targeted Chimeric Antigen Receptor T-cell Therapy: a Multicenter Cohort StudyJonathan Huggins, Julia A Messina, Jennifer Saullo, et al.Nature Genetics|November 13, 2012
The genetic landscape of mutations in Burkitt lymphomaCassandra Love, Zhen Sun, Dereje Jima, et al.The Journal of Experimental Medicine|April 21, 2017
Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2Andrea B Moffitt, Sarah L Ondrejka, Matthew McKinney, et al.The Lancet. Haematology|July 21, 2024
Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in patients with B-cell malignancies: analysis of the Richter transformation subgroup from the multicentre, open-label, phase 1/2 BRUIN studyWilliam G Wierda, Nirav N Shah, Chan Y Cheah, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 6, 2020
Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in OncologyRichard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.The Lancet. Haematology|May 2, 2026
Safety and activity of pirtobrutinib in patients with relapsed or refractory Waldenström macroglobulinaemia: 5-year follow-up of the open-label, multicentre, phase 1/2 BRUIN trialM Lia Palomba, Manish R Patel, Toby A Eyre, et al.Cancer Discovery|January 27, 2017
The Genetic Basis of Hepatosplenic T-cell LymphomaMatthew McKinney, Andrea B Moffitt, Philippe Gaulard, et al.Pageof 2